End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
840.4 INR | +1.24% | +1.39% | +27.91% |
Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Sales 2024 | 22.83B 274M | Sales 2025 * | 25.79B 309M | Capitalization | 103B 1.23B |
---|---|---|---|---|---|
Net income 2024 | 4.71B 56.44M | Net income 2025 * | 5.5B 65.97M | EV / Sales 2024 | 4.17 x |
Net cash position 2024 * | 3.5B 41.92M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.99 x |
P/E ratio 2024 |
20.2
x | P/E ratio 2025 * |
18.7
x | Employees | 1,824 |
Yield 2024 * |
2.51% | Yield 2025 * |
2.86% | Free-Float | 15.72% |
Latest transcript on Glenmark Life Sciences Limited
1 day | +1.24% | ||
1 week | +1.39% | ||
Current month | +1.39% | ||
1 month | +3.69% | ||
3 months | -3.63% | ||
6 months | +33.53% | ||
Current year | +27.91% |
Managers | Title | Age | Since |
---|---|---|---|
Yasir Rawjee
CEO | Chief Executive Officer | 58 | 19-08-12 |
Director of Finance/CFO | - | 22-05-31 | |
Compliance Officer | - | 21-02-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Manju Agarwal
BRD | Director/Board Member | 66 | 20-10-29 |
Yasir Rawjee
CEO | Chief Executive Officer | 58 | 19-08-12 |
Sumantra Mitra
HRO | Human Resources Officer | 49 | 18-10-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 840.4 | +1.24% | 70,300 |
24-05-07 | 830.1 | -0.10% | 73,684 |
24-05-06 | 831 | +0.12% | 87,052 |
24-05-03 | 830 | -1.33% | 77,779 |
24-05-02 | 841.2 | +1.48% | 230,238 |
End-of-day quote NSE India S.E., May 07, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.91% | 1.23B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.70% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- GLS Stock